Zolotov, E., Biran, N., Roney, P., Ahn, J., Rees, M., Banerjee, R., Tan, M., Sidana, S., Dima, D., DeJarnette, S., Afrough, A., Gaballa, M., Pasvolsky, O., Khouri, J., Raza, S., Goel, U., Anwer, F., Zanwar, S., Lin, Y., Atrash, S., Reshef, R., Gordillo, C., Portuguese, A., Cassano, R. C., Bhurtel, E., Kort, J., Shune, L., Geer, M., Xie, Z., Puglianini, O. A. C., Hansen, D., Freeman, C. L., Locke, F., Nishihori, T., Grajales-Cruz, A., Davis, J., Green, K., Herr, M., Hassan, H., Mikkilineni, L., Hosoya, H., Sannareddy, A., Patel, K., Anderson, L., Khan, A., Sborov, D., Wagner, C., Cahoon, C., Fortuna, G. G., Purvey, S., Ferreri, C. (2025). Subsequent primary malignancies after CAR-T therapy: A study from the US multiple myeloma immunotherapy consortium. Blood. https://doi.org/10.1182/blood-2025-5852